Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: Sanofi
Condition: Ductal Carcinoma
NCT00461344
Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: None
Stopped reason
Context when available
due to slow recruitment of patients